TH98280B - The pulse-acting formulation of phenylephrine and its pharmaceutical constituents. - Google Patents
The pulse-acting formulation of phenylephrine and its pharmaceutical constituents.Info
- Publication number
- TH98280B TH98280B TH701002726A TH0701002726A TH98280B TH 98280 B TH98280 B TH 98280B TH 701002726 A TH701002726 A TH 701002726A TH 0701002726 A TH0701002726 A TH 0701002726A TH 98280 B TH98280 B TH 98280B
- Authority
- TH
- Thailand
- Prior art keywords
- pharmaceutical
- coated
- components
- phenylephrine
- pulse
- Prior art date
Links
- SONNWYBIRXJNDC-VIFPVBQESA-N Phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 title claims abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 229960001802 Phenylephrine Drugs 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title abstract 2
- 239000000470 constituent Substances 0.000 title 1
- 239000000306 component Substances 0.000 claims abstract 6
- 239000005426 pharmaceutical component Substances 0.000 claims abstract 5
- 210000000936 Intestines Anatomy 0.000 claims abstract 3
- 239000004480 active ingredient Substances 0.000 claims abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract 3
- 239000007787 solid Substances 0.000 claims abstract 3
- 239000000126 substance Substances 0.000 claims abstract 3
- 150000003839 salts Chemical class 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- 210000003298 Dental Enamel Anatomy 0.000 claims 1
- 241001331845 Equus asinus x caballus Species 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000005020 pharmaceutical industry Methods 0.000 claims 1
- 230000000202 analgesic Effects 0.000 abstract 1
- -1 analgesic Substances 0.000 abstract 1
- 230000001387 anti-histamine Effects 0.000 abstract 1
- 230000001754 anti-pyretic Effects 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- 239000002221 antipyretic Substances 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
Abstract
การประดิษฐ์เปิดเผยสูตรผสมที่ออกฤทธิ์แบบพัลส์หรือองค์ประกอบทางเภสัชกรรมที่ ประกอบรวมด้วยเฟนิลเอพฟรีน องค์ประกอบทางเภสัชกรรมประกอบรวมด้วยส่วนประกอบที่ ออกฤทธิ์ทันที และส่วนประกอบที่เคลือบแบบที่ใช้กับลำไส้ที่เตรียมสูตรผสมร่วมกันในรูป ของแข็งหรือในสารแขวนลอยอย่างใดอย่างหนึ่ง ส่วนประกอบที่เคลือบแบบที่ใช้กับลำไส้ ประกอบรวมด้วยผลึกขนาดจิ๋วที่ล่อผลึกด้วยเฟนิลเอพฟรีนเป็นส่วนผสมออกฤทธิ์ และเคลือบด้วย ผิวเคลือบที่ไวต่อ pH เพื่อยืดเวลาการปลดปล่อยของเฟนิลเอพฟรีน องค์ประกอบทางเภสัชกรรม ยังสามารถประกอบรวมด้วยสารออกฤทธิ์อย่างน้อยหนึ่งชนิดที่เลือกจากกลุ่มที่ประกอบด้วยแอนติ ฮิสทามีน, ยาระงับปวด, ยาแก้ไข้, สารต้านการอักเสบที่ไม่ใช่สเทอรอยด์ และของผสมของสารออก ฤทธิ์ดังกล่าวสองชนิดหรือมากกว่า The invention discloses a pulse-acting formulation or a pharmaceutical component that Included with phenyl epiphany Pharmaceutical components include components that Act immediately And components that were coated in the form of intestines that were prepared to mix together in the form Solid or in either a suspension Ingredients that are coated as used on the intestines It is composed of tiny crystals that are lured with phenyl epiphany as an active ingredient. And coated with PH-sensitive coating to prolong the release time of phenylephrine. Pharmaceutical components It can also contain at least one active ingredient chosen from the group containing antihistamine, analgesic, antipyretic, non-steroidal anti-inflammatory agent. And mixtures of substances released Two or more such effects
Claims (2)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH98280A TH98280A (en) | 2009-09-17 |
| TH98280B true TH98280B (en) | 2009-09-17 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP17013617A (en) | “PHARMACEUTICAL COMBINATION COMPRISING 3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYL-PROPYL)-PHENOL AND NSAID” | |
| BRPI0414581C1 (en) | compound, pharmaceutical composition comprising said compound and use of said compound | |
| EA200801767A1 (en) | PHARMACEUTICAL COMPOSITION FOR AEROSOL SPRAYING WITH TWO ACTING SUBSTANCES AND AT LESS THAN ONE SURFACE ACTIVE SUBSTANCE | |
| BRPI0508540A (en) | compound, pharmaceutical composition, and use of a compound | |
| CL2007002128A1 (en) | DERIVATIVES OF N'-CIANO-N-HALOGENOALQUIL-IMIDAMIDA; PROCEDURE FOR THE PREPARATION OF SUCH COMPOUND; PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT; AND USE OF THE COMPOUND TO COMBAT ANIMAL PARASITES. | |
| BRPI0415121A (en) | particulate material, solid dosage form, method of manufacturing it, and use of a particulate material or solid dosage form | |
| NO20062051L (en) | Pharmaceutical active ingredient-containing formulation with coating | |
| CY1111369T1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING 3- (3-DIMETHYLAMINE-1-ETHYL-2-Methyl-PROPYL) -PHENOL AND PARAKETAMOL | |
| AR061165A1 (en) | FORMULATIONS OF PULSED RELEASE OF PHENYLEFRINE AND PHARMACEUTICAL COMPOSITIONS | |
| RS54420B1 (en) | Formulation comprising phenylaminopyrimidine derivative as active agent | |
| TH98280B (en) | The pulse-acting formulation of phenylephrine and its pharmaceutical constituents. | |
| TH98280A (en) | The pulse-acting formulation of phenylephrine and its pharmaceutical constituents. | |
| EA200900266A1 (en) | COMPOSITION FOR AEROSOL INHALATION OF β-AGONISTS | |
| TH100032B (en) | Compound drug formulation and pharmaceutical composition of phenylephrine for colon absorption. | |
| TH104743B (en) | Solid diffusion product containing N-aryl urea compounds. | |
| TH95360A (en) | DPP IV inhibitor combination formula | |
| TH112705A (en) | Pharmaceutical constituents that can be distributed in the mouth for administration through mucous membranes in the mouth or under the tongue of agomelatine. | |
| TH74299B (en) | Oral antifungal dosage forms And method for preparation | |
| TH153722A (en) | Epoxy-iicosatrienoic acid-like substances and methods of their production and use of Same thing | |
| TH112705B (en) | Pharmaceutical constituents that can be distributed in the mouth for administration through the mucous membranes in the mouth or under the tongue of agomelatine. | |
| TH113758B (en) | Pharmaceutical components for oral dosing | |
| TH76782A (en) | Spyrocondens New quinalinones and their use as a phosphodynamic inhibitor | |
| TH120957A (en) | New crystal form of 7-Chloro-N, N, 5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino [4,5-b] indo. L-1-acetamide, process, composition and use of these substances | |
| TH78146B (en) | New Benz Emidasol derivative | |
| TH131672B (en) | A method for the preparation of a pharmaceutical component intended for oral administration, which consists of one or more active ingredients and the constituents thereof. |